40 Participants Needed

Tuberoplasty vs Balloon Spacer for Rotator Cuff Tears

AR
Overseen ByAllison Rao
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to examine bone-to-bone contact between the tuberosity as compared to a subacromial balloon spacer procedure. Using biplanar fluoroscopy to determine the three-dimensional (3D) motion of the shoulder compared pre-procedure to post-procedure, the investigators will be able to assess 1) the bone-to-bone contact of the tuberosity and acromion in the setting of a massive posterior superior rotator cuff tear 2) if the placement of a dermal allograft over the tuberosity does indeed decrease bone contact and 3) if the placement of a subacromial balloon spacer decreases bone-to-bone contact. Doing so will allow assessment of the relative contribution of the implant for arm elevation versus potential compensatory motion of increased scapulothoracic motion. The investigators will also be able to correlate this to patient-reported outcomes of pain and shoulder function.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is the subacromial balloon spacer safe for treating rotator cuff tears?

The subacromial balloon spacer, used for treating massive irreparable rotator cuff tears, has shown significant improvement in shoulder function and high patient satisfaction with limited need for additional surgery. It is made of a biodegradable material that is expected to fully dissolve within 12 months, and studies have reported positive safety outcomes in humans.12345

How is the treatment for rotator cuff tears using a balloon spacer or tuberoplasty different from other treatments?

The balloon spacer and tuberoplasty treatment for rotator cuff tears is unique because it involves inserting a balloon-like device into the shoulder to create space and reduce friction, which is different from traditional surgical repairs that directly stitch or reattach the torn tendons.678910

Research Team

AR

Allison Rao

Principal Investigator

University of Minnesota

Eligibility Criteria

This trial is for individuals with a severe rotator cuff injury or tear. Participants should be suitable candidates for shoulder procedures and willing to undergo imaging tests before and after the treatment. Specific details about inclusion and exclusion criteria are not provided, but typically these would outline health conditions that qualify or disqualify someone from participating.

Inclusion Criteria

Centered humeral head on X-ray examination
My main issue is pain.
I have a severe shoulder tear that cannot be repaired.
See 2 more

Exclusion Criteria

Acromiohumeral distance less than 7 mm on upright anterior-posterior (AP) radiograph
I am under 65 years old.
My subscapularis muscle is affected.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo either biologic tuberoplasty or subacromial balloon spacer surgery for massive irreparable rotator cuff tears

1 week
1 visit (in-person)

Follow-up

Participants are monitored for changes in bone-to-bone contact, shoulder range of motion, and shoulder function using various assessments

12 months
Multiple visits at 1 week, 6 weeks, 3 months, 6 months, and 12 months postoperatively

Treatment Details

Interventions

  • Balloon Spacer
  • Tuberoplasty
Trial Overview The study compares two treatments for rotator cuff injuries: biologic tuberoplasty versus subacromial balloon spacer. It aims to see which method better reduces bone-to-bone contact in the shoulder using advanced imaging techniques and will also measure patient pain relief and improved shoulder function.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: subacromial balloon spacer groupExperimental Treatment1 Intervention
massive irreparable rotator cuff tear involving the supraspinatus and infraspinatus, no involvement of the subscapularis, centered humeral head on X-Ray examination, and a primary complaint of pain, randomized to subacromial balloon spacer.
Group II: biologic tuberoplasty groupExperimental Treatment1 Intervention
massive irreparable rotator cuff tear involving the supraspinatus and infraspinatus, no involvement of the subscapularis, centered humeral head on X-Ray examination, and a primary complaint of pain, randomized to biologic tuberoplasty surgery.

Balloon Spacer is already approved in European Union, United States for the following indications:

๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as InSpace subacromial balloon spacer for:
  • Massive irreparable rotator cuff tears
๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as InSpace subacromial balloon spacer for:
  • Massive irreparable rotator cuff tears

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials
1,459
Recruited
1,623,000+

Findings from Research

The InSpace balloon spacer implant showed significant improvements in shoulder function and pain relief compared to partial repair in patients with irreparable rotator cuff tears, with 83% of patients achieving clinically important improvements after 24 months.
The InSpace procedure had a shorter operative time and resulted in greater forward shoulder elevation at multiple follow-up points, indicating a quicker recovery compared to traditional partial repair methods.
InSpace Implant Compared with Partial Repair for the Treatment of Full-Thickness Massive Rotator Cuff Tears: A Multicenter, Single-Blinded, Randomized Controlled Trial.Verma, N., Srikumaran, U., Roden, CM., et al.[2022]
The use of a biodegradable subacromial balloon-shaped spacer (InSpace) during rotator cuff repairs may significantly improve repair strength and reduce failure rates by protecting the tendon repair and centering the humeral head.
This spacer is implanted arthroscopically after the rotator cuff repair, and its correct placement is confirmed by ensuring free arm movement, which helps reduce friction and flatten dog-ear formations at the repair site.
Subacromial spacer placement for protection of rotator cuff repair.Szรถllรถsy, G., Rosso, C., Fogerty, S., et al.[2022]
The biodegradable subacromial balloon spacer (InSpace) has shown significant clinical benefits for patients with massive irreparable rotator cuff tears (MIRCTs), including improved shoulder function and high patient satisfaction over a mean follow-up of 3 years.
In a recent multicenter randomized controlled trial involving 184 patients, both the balloon spacer and arthroscopic partial repair groups demonstrated significant improvements in shoulder function, indicating that the balloon spacer is an effective treatment option for MIRCTs.
Subacromial Balloon Spacer for Massive Irreparable Rotator Cuff Tears.Srikumaran, U., Russo, R., Familiari, F.[2023]

References

InSpace Implant Compared with Partial Repair for the Treatment of Full-Thickness Massive Rotator Cuff Tears: A Multicenter, Single-Blinded, Randomized Controlled Trial. [2022]
Subacromial spacer placement for protection of rotator cuff repair. [2022]
Subacromial Balloon Spacer for Massive Irreparable Rotator Cuff Tears. [2023]
Subacromial Balloon Implantation for the Treatment of Irreparable Posterosuperior Rotator Cuff Tears. [2023]
Satisfactory mid-term outcome of subacromial balloon spacer for the treatment of irreparable rotator cuff tears. [2022]
Comparison between traditional and small-diameter tube-assisted bronchoscopic balloon dilatation in the treatment of benign tracheal stenosis. [2018]
Intermediate-Term Outcomes of Slide Tracheoplasty in Pediatric Patients With Ring-Sling Complex. [2022]
Single-port robotic transcervical long-segment thoracic tracheal reconstruction: Cadaveric proof-of-concept study. [2022]
Transmural rupture and cartilage ring fracture in a tracheobronchial tuberculosis patient. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Balloon dilation causing tracheal rupture: Endoscopic management and literature review. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity